達仁堂、サキサグリプチン・メトホルミン徐放錠（Ⅰ）の医薬品登録証明書を取得

Darentang, a branch of Tianjin Zhongxin Pharmaceutical, received a drug registration certificate for a new diabetes drug, indicating product approval and market entry.